Discontinuation Timeline for HEMOFIL ®M and RECOMBINATE

Takeda has updated the information for how long the these treatments will be available for patients who are still using these therapies.

Read more

Source: National Bleeding Disorders Foundation, HemAware, April 2026

Back to all News